focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEO.L Regulatory News (APEO)

  • There is currently no data for APEO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and Investment Manager Update

27 Mar 2024 15:50

RNS Number : 5710I
abrdn Private Equity Opp Trst plc
27 March 2024

abrdn Private Equity Opportunities Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

27 March 2024

Result of Annual General Meeting & Investment Manager Update

Result of AGM

At the Annual General Meeting of abrdn Private Equity Opportunities Trust plc (the "Company" or "APEO") held on Wednesday, 27 March 2024, all the Resolutions as set out in full in the Notice of Meeting included within the Company's Annual Report for the year ended 30 September 2023, available on the Company's website www.abrdnpeot.com*, were duly passed.

Proxy votes

The proxy votes received in respect of the AGM resolutions proposed at the meeting are shown in the table below:

For and Discretionary

Against

Votes

Total Votes

Resolution

Number

No. of

Votes

% of

Votes Cast

No. of

Votes

% of

Votes Cast

Withheld

(excluding Votes Withheld)

1. Receive the Annual Report and Financial Statements

109,836,666

100.00

3,722

0.00

11,691

109,840,388

2. Approve the Directors' Remuneration Report

109,660,172

99.86

155,541

0.14

36,366

109,815,713

3. Approve the Dividend Policy

109,838,935

100.00

3,722

0.00

9,422

109,842,657

4. Re-elect Mr Agble

109,783,542

99.98

20,309

0.02

48,228

109,803,851

5. Re-elect Mr Devine

109,748,143

99.95

51,436

0.05

52,500

109,799,579

6. Re-elect Ms Seymour-Williams

109,778,477

99.99

15,957

0.01

57,645

109,794,434

7. Re-elect Ms Stillhart

109,788,129

99.99

15,722

0.01

48,228

109,803,851

8. Re-elect Mr Thomson

109,779,716

99.98

24,135

0.02

48,228

109,803,851

9. Re-appoint BDO LLP as Auditor

109,787,683

99.96

47,269

0.04

17,127

109,834,952

10. Remuneration of the Auditor

109,823,435

99.99

15,573

0.01

13,071

109,839,008

11. Allotment of new equity

109,814,610

99.98

27,015

0.02

10,454

109,841,625

12. Disapply pre-emption rights

109,174,155

99.41

653,166

0.59

24,758

109,827,321

13. Authorise market purchases of ordinary shares

107,895,091

98.23

1,941,487

1.77

15,501

109,836,578

14. Approve holding meetings on less than 14 days' notice

109,722,870

99.90

111,598

0.10

17,611

109,834,468

15. Adoption of new Articles of Association

109,738,298

99.92

83,135

0.08

30,646

109,821,433

Copies of the resolutions passed under special business will shortly be submitted to the National Storage Mechanism and will be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism*.

*Neither the NSM website nor the Company's website nor the content of any website accessible from hyperlinks on those websites (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

Investment Manager Update

At the AGM, Mr Devine, the APEO Chair, also provided an update, further to the Company's announcement on 16 October 2023, on the status of sale by abrdn plc ("abrdn") of its European-headquartered Private Equity business, including the Company's investment manager, abrdn Capital Partners LLP, to an indirect subsidiary of Patria Investments Limited ("Patria")(the "Transaction").

Mr Devine said:

"In October 2023, abrdn announced the conditional sale of its European-headquartered Private Equity business, which includes APEO's investment manager, abrdn Capital Partners LLP, to an indirect subsidiary of Patria Investments Limited, a global alternative asset manager established in Latin America.

As I mentioned in our Annual Report, the Board has been undertaking extensive diligence on the proposed Transaction with abrdn, our investment management team, and with Patria, to fully understand the impact of the sale, and what it means for APEO and its shareholders.

I am pleased to confirm that the Board has completed its due diligence exercise and has agreed to consent to the Transaction by waiving the "Manager Change of Control" provisions set out in our Investment Management Agreement.

During our diligence, we received various assurances, including that there will be: (i) no change to the management and administration services which are provided to APEO; (ii) no change to APEO's investment management process; and (iii) no change to the personnel managing APEO. Importantly, we also received comfort that the Transaction will be cost neutral for the Company - there are not expected to be any additional costs to the Company (and so shareholders) as a result of it.

The Transaction remains subject to regulatory approval and, upon receipt of that approval, the Board is excited to continue to work with APEO's management team, and the wider team at Patria."

For abrdn Private Equity Opportunities Trust plc

abrdn Holdings Limited

Company Secretary

27 March 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGJRMATMTITBFI
Date   Source Headline
30th Apr 202410:48 amRNSDirector/PDMR Shareholding
29th Apr 20244:53 pmRNSChange of Name
17th Apr 20247:00 amRNSEstimated NAV at 31 March 2024
16th Apr 202410:26 amRNSDirector/PDMR Shareholding
15th Apr 20244:51 pmRNSUpdate from QuotedData
8th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20244:37 pmRNSQuarterly disclosure
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20243:50 pmRNSResult of AGM and Investment Manager Update
19th Mar 20247:00 amRNSEstimated NAV at 29 February 2024
13th Mar 20247:00 amRNSFirst Interim Dividend
11th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20242:07 pmEQSEdison issues update on abrdn Private Equity Opportunities Trust (APEO): Returns and buyback help narrow the discount
26th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSEstimated NAV at 31 January 2024
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSAnnual Financial Report
30th Jan 20241:13 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSShare Buyback Programme
17th Jan 20247:00 amRNSEstimated NAV at 31 December 2023
12th Jan 20247:00 amRNSNotice of Results
5th Jan 20249:03 amRNSQuarterly disclosure
19th Dec 20237:00 amRNSEstimated NAV at 30 November 2023
14th Dec 20231:14 pmRNSReplacement - Fourth Interim Dividend
13th Dec 20237:00 amRNSFourth Interim Dividend
15th Nov 20237:00 amRNSEstimate NAV at 31 October 2023
31st Oct 20232:32 pmRNSHolding(s) in Company
31st Oct 20232:31 pmRNSHolding(s) in Company
31st Oct 20232:30 pmRNSHolding(s) in Company
31st Oct 202310:36 amRNSDirector/PDMR Shareholding
25th Oct 202311:34 amEQSEdison issues update on abrdn Private Equity Opportunities Trust (APEO): Resilient NAV and stable balance sheet
18th Oct 20237:00 amRNSEstimated NAV at 30 September 2023
16th Oct 202311:09 amRNSStatement regarding Investment Manager
6th Oct 20234:16 pmRNSQuotedData's Weekly News & Interview
4th Oct 20239:08 amRNSQuarterly disclosure
25th Sep 20237:00 amRNSEstimate NAV at 31 August 2023
14th Sep 20237:00 amRNSThird Interim Dividend
12th Sep 20239:56 amRNSAnnual Overview from QuotedData
18th Aug 20234:11 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSEstimated NAV at 31 July 2023
1st Aug 20233:09 pmRNSDirector/PDMR Shareholding
18th Jul 202312:11 pmRNSEdison issues update on abrdn PEO Trust
17th Jul 20237:00 amRNSEstimated NAV at 30 June 2023
7th Jul 20237:00 amRNSDoc re. Half Yearly Report
5th Jul 20239:19 amRNSQuarterly disclosure
28th Jun 20239:16 amRNSHalf-year Report - Replacement
28th Jun 20237:00 amRNSHalf-year Report
20th Jun 20237:00 amRNSEstimated NAV at 31 May 2023
14th Jun 20237:00 amRNSSecond Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.